Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Solid Tumor Skin Cancer

Skin Cancer
23-04-2024 Checkpoint Inhibitors News

Some reassurance on ICI use in pregnancy from VigiBase analysis

Read more

A study has found little over-reporting of adverse maternofetal outcomes among pregnant women with cancer using ICIs versus other anticancer agents.

Editor's Choice

Primary melanoma of the lung

Open Access Melanoma Case Study

A report of primary endobronchial melanoma that sheds light on the clinical presentation, histopathology, diagnostic challenges, and treatment options for this rare entity.

Individualized neoantigen therapy may benefit people with resected melanoma

25-01-2024 Melanoma News

Adding a novel mRNA-based individualized neoantigen therapy to adjuvant pembrolizumab could improve the outcomes of patients with completely resected melanoma.

Treatment of melanoma brain and leptomeningeal metastases

Melanoma Review

The past decade has seen significant advancements in the treatment of melanoma brain and leptomeningeal metastases. The sequence of therapies depends on factors such as the number and size of metastases, status of systemic disease control, and neurological symptoms.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Register today

Latest News

Some reassurance on ICI use in pregnancy from VigiBase analysis

23-04-2024 Checkpoint Inhibitors News

Smoking linked to worse melanoma survival

09-02-2024 Melanoma News

Individualized neoantigen therapy may benefit people with resected melanoma

25-01-2024 Melanoma News

Genetic counseling ‘should be considered’ for patients with early-onset MCC

05-01-2024 Merkel Cell Carcinoma News

Encephalopathy is the predominant neurological irAE due to checkpoint inhibitors

13-12-2023 Encephalopathy News

Emotional distress linked to poor neoadjuvant immunotherapy outcomes

24-11-2023 Melanoma News
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine

Case Studies

Primary melanoma of the lung

Open Access Melanoma Case Study

A report of primary endobronchial melanoma that sheds light on the clinical presentation, histopathology, diagnostic challenges, and treatment options for this rare entity.

Primary melanoma presenting in the cervical spine

Open Access Melanoma Case Study

When primary CNS melanoma has a spinal location, it typically manifests in the thoracic sections. This case report describes a patient with an uncommon presentation in the cervical spine. 

Current Reviews

Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis

Melanoma Systematic Review

Melanoma, a malignant neoplasm of melanocytes, is characterised by its rapid proclivity for both regional and distant metastasis, rendering it a leading cause of global morbidity and mortality [ 1 ]. While melanoma accounts for only a fraction of …

Metastatic cutaneous squamous cell carcinoma accounts for nearly all squamous cell carcinomas of the parotid gland

Open Access Salivary Gland Cancer REVIEW AND PERSPECTIVES

Primary squamous cell carcinoma of the parotid gland (pSCCP) has long been recognized as a separate entity and is included in the WHO classifications of salivary gland tumors. However, it is widely accepted among head and neck pathologists that …

Immune Checkpoint Inhibitors in Geriatric Oncology

Checkpoint Inhibitors REVIEW

Cancer is widely considered a disease of aging. The care of older adults with cancer is complicated by factors such as frailty, multiple comorbidities, and age-related organ dysfunction [ 1 ]. These issues pose specific challenges to optimal …

Isolated Limb Perfusion for Extremity Soft Tissue Sarcoma and Malignant Melanoma

Soft Tissue Sarcoma Review Article

Isolated limb perfusion (ILP) is a regional chemotherapy technique used in the treatment of locally advanced or unresectable extremity soft tissue sarcoma (ESTS) or malignant melanoma (MM) of the limbs. It allows for high concentrations of …

Case-Based Insights: Oncology and Hematology (Link opens in a new window)


Refresh your knowledge in Oncology and Hematology: 

  • 45 clinical cases across different topics with relevant clinical images
  • Written by renowned experts 
  • Knowledge-check questions with answers
Try the first set of cases now

CME & eLearning

Cases

Oncology and Hematology

Take on interactive case studies with a focus on hematology. Each case has been prepared by renowned experts in the field and features knowledge-check questions with answers to help keep you and your practice up to date.

Developed by: Springer Medizin
Webinar | 16-05-2023 | 17:30 (CEST)

Keynote webinar | Spotlight on cardio-oncology

Watch now

An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.

Prof. Rudolf de Boer
Prof. Lorenz Lehmann
Dr. Teresa Lopéz Fernández
Developed by: Springer Medicine

Further Reading

Metastatic cutaneous squamous cell carcinoma accounts for nearly all squamous cell carcinomas of the parotid gland

Open Access Salivary Gland Cancer REVIEW AND PERSPECTIVES

Primary squamous cell carcinoma of the parotid gland (pSCCP) has long been recognized as a separate entity and is included in the WHO classifications of salivary gland tumors. However, it is widely accepted among head and neck pathologists that …

What patients with advanced cancer experience as helpful in navigating their life with a long-term response: a qualitative study

Open Access Melanoma Research

Size selection of intrahepatic lesions for cryoablation contributes to abscopal effect and long-term survival in patients with liver metastatic melanoma receiving PD-1 blockade therapy

Open Access Melanoma Research

Liver metastasis remains a clinical challenge for immune checkpoint inhibitor therapy in melanoma, with an estimated response rate ranging from 3 to 10% [ 1 ]. Recent translational studies have dissected the mechanism of an immune suppression …

Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data

Open Access Urothelial Cancer Original Research

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by targeting the brakes of the immune system and restoring antitumor activity. The clinical indications for ICIs, one of the novel standard treatments for various cancer …

Image Credits